{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:56:16Z","timestamp":1791402976235,"version":"4.3.3"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008984","name":"International Anesthesia Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008518","name":"University of Texas McGovern Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.canlet.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T22:24:32Z","timestamp":1613600672000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Loss of CD73 shifts transforming growth factor-\u03b21 (TGF-\u03b21) from tumor suppressor to promoter in endometrial cancer"],"prefix":"10.1016","volume":"505","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-0128","authenticated-orcid":false,"given":"Katherine C.","family":"Kurnit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Draisey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Kazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan H.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-9281","authenticated-orcid":false,"given":"Jerry B.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuSu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-7769","authenticated-orcid":false,"given":"Jessica L.","family":"Bowser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jso.23056","article-title":"High expression of CD73 as a poor prognostic biomarker in human colorectal cancer","volume":"106","author":"Wu","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"27","key":"10.1016\/j.canlet.2021.01.030_bib2","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1073\/pnas.1222251110","article-title":"CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer","volume":"110","author":"Loi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.canlet.2021.01.030_bib3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3748\/wjg.v19.i12.1912","article-title":"Expression and clinical significance of CD73 and hypoxia-inducible factor-1alpha in gastric carcinoma","volume":"19","author":"Lu","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.canlet.2021.01.030_bib4","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-14-3569","article-title":"CD73 is associated with poor prognosis in high-grade serous ovarian cancer","volume":"75","author":"Turcotte","year":"2015","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib5","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3892\/ol.2015.3138","article-title":"Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma","volume":"9","author":"Yu","year":"2015","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/annonc\/mdx730","article-title":"Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial","volume":"29","author":"Buisseret","year":"2018","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00109-018-01742-0","article-title":"The distinct role of CD73 in the progression of pancreatic cancer","volume":"97","author":"Zhou","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib8","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","article-title":"CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression","volume":"70","author":"Jin","year":"2010","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"Stagg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib10","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","article-title":"CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis","volume":"71","author":"Stagg","year":"2011","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib11","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1172\/JCI45559","article-title":"CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice","volume":"121","author":"Wang","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.canlet.2021.01.030_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/eji.201041292","article-title":"Altered purinergic signaling in CD73-deficient mice inhibits tumor progression","volume":"41","author":"Yegutkin","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2021.01.030_bib13","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/0008-5472.CAN-12-0420","article-title":"CD73-deficient mice are resistant to carcinogenesis","volume":"72","author":"Stagg","year":"2012","journal-title":"Canc. Res."},{"issue":"19","key":"10.1016\/j.canlet.2021.01.030_bib14","doi-asserted-by":"crossref","first-page":"31977","DOI":"10.18632\/oncotarget.16667","article-title":"Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib15","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.stemcr.2018.02.009","article-title":"CD73 regulates stemness and epithelial-mesenchymal transition in ovarian cancer-initiating cells","volume":"10","author":"Lupia","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3892\/ijo.2015.3299","article-title":"CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells","volume":"48","author":"Katsuta","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"20","key":"10.1016\/j.canlet.2021.01.030_bib17","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1158\/0008-5472.CAN-17-0707","article-title":"CD73 promotes resistance to HER2\/ErbB2 antibody therapy","volume":"77","author":"Turcotte","year":"2017","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6","article-title":"Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance","volume":"68","author":"Ujhazy","year":"1996","journal-title":"Int. J. Canc."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2021.01.030_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-008-9877-3","article-title":"The role of ecto-5'-nucleotidase\/CD73 in glioma cell line proliferation","volume":"319","author":"Bavaresco","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00441-013-1752-1","article-title":"NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer","volume":"355","author":"Xiong","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1172\/JCI79380","article-title":"Loss of CD73-mediated actin polymerization promotes endometrial tumor progression","volume":"126","author":"Bowser","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.canlet.2021.01.030_bib22","first-page":"3702","article-title":"5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia","volume":"49","author":"Rackley","year":"1989","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib23","first-page":"1","article-title":"Cell-type specific CD73 expression is an independent prognostic factor in bladder cancer","volume":"40","author":"Koivisto","year":"2018","journal-title":"Carcinogenesis"},{"issue":"25","key":"10.1016\/j.canlet.2021.01.030_bib24","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1091\/mbc.e14-06-1167","article-title":"Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73)","volume":"25","author":"Snider","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.canlet.2021.01.030_bib25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep4.1410","article-title":"Tumor-selective altered glycosylation and functional attenuation of CD73 in human hepatocellular carcinoma","volume":"3","author":"Alcedo","year":"2019","journal-title":"Hepatol Commun"},{"issue":"Pt 2","key":"10.1016\/j.canlet.2021.01.030_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5'-Nucleotidase: molecular structure and functional aspects","volume":"285","author":"Zimmermann","year":"1992","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib27","doi-asserted-by":"crossref","first-page":"G904","DOI":"10.1152\/ajpgi.00015.2012","article-title":"Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase\/CD73 via specific SP1 and SMAD promoter elements","volume":"303","author":"Fausther","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"10","key":"10.1016\/j.canlet.2021.01.030_bib28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/eji.201141512","article-title":"Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-beta","volume":"41","author":"Regateiro","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2021.01.030_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","article-title":"Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression","volume":"36","author":"Chalmin","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib30","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.4049\/jimmunol.1400578","article-title":"Role of TGF-beta signaling in generation of CD39+CD73+ myeloid cells in tumors","volume":"193","author":"Ryzhov","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1320011","article-title":"CD39\/CD73 upregulation on myeloid-derived suppressor cells via TGF-beta-mTOR-HIF-1 signaling in patients with non-small cell lung cancer","volume":"6","author":"Li","year":"2017","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-018-0441-8","article-title":"Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells","volume":"6","author":"Wang","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2021.01.030_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/scd.2018.0183","article-title":"Mesenchymal stromal cells derived from normal cervix and cervical cancer tumors increase CD73 expression in cervical cancer cells through TGF-beta1 production","volume":"28","author":"Avila-Ibarra","year":"2019","journal-title":"Stem Cell. Dev."},{"issue":"5","key":"10.1016\/j.canlet.2021.01.030_bib34","first-page":"1539","article-title":"Expression and intracellular localization of Smad proteins in human endometrial cancer","volume":"10","author":"Piestrzeniewicz-Ulanska","year":"2003","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.canlet.2021.01.030_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1447-0756.2000.tb01305.x","article-title":"The association of transforming growth factor-beta 1 with myometrial invasion of endometrial carcinomas through effects on matrix metalloproteinase","volume":"26","author":"Yabushita","year":"2000","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2004.06.032","article-title":"TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas","volume":"95","author":"Piestrzeniewicz-Ulanska","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib37","first-page":"15","article-title":"TGFbeta signaling supports survival and metastasis of endometrial cancer cells","volume":"2009","author":"Lei","year":"2009","journal-title":"Canc. Manag. Res."},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/1535-7163.MCT-10-1019","article-title":"High-risk endometrial carcinoma profiling identifies TGF-beta1 as a key factor in the initiation of tumor invasion","volume":"10","author":"Muinelo-Romay","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"issue":"38","key":"10.1016\/j.canlet.2021.01.030_bib39","doi-asserted-by":"crossref","first-page":"61262","DOI":"10.18632\/oncotarget.11311","article-title":"TGF-beta1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1\/2 signaling pathways","volume":"7","author":"Xiong","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.canlet.2021.01.030_bib40","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.1806838116","article-title":"Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma","volume":"116","author":"Monsivais","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.canlet.2021.01.030_bib41","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1073\/pnas.1806862116","article-title":"Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer","volume":"116","author":"Kriseman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.canlet.2021.01.030_bib42","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.153.12.5730","article-title":"Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine","volume":"153","author":"Planchon","year":"1994","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.canlet.2021.01.030_bib43","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1128\/IAI.68.10.5635-5644.2000","article-title":"Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes","volume":"68","author":"Roche","year":"2000","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib44","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0002-9440(10)61243-6","article-title":"Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability","volume":"167","author":"Howe","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.canlet.2021.01.030_bib45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1753425917690815","article-title":"TGF-beta1 protects intestinal integrity and influences Smads and MAPK signal pathways in IPEC-J2 after TNF-alpha challenge","volume":"23","author":"Xiao","year":"2017","journal-title":"Innate Immun."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib46","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41598-018-22821-9","article-title":"TGF-beta1 promotes cell barrier function upon maturation of corneal endothelial cells","volume":"8","author":"Beaulieu Leclerc","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.canlet.2021.01.030_bib47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGFbeta action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"15","key":"10.1016\/j.canlet.2021.01.030_bib48","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1158\/0008-5472.CAN-18-2019","article-title":"A new switch for TGFbeta in cancer","volume":"79","author":"Yeh","year":"2019","journal-title":"Canc. Res."},{"issue":"7","key":"10.1016\/j.canlet.2021.01.030_bib49","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1073\/pnas.89.7.2759","article-title":"Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1","volume":"89","author":"Gerwin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncb1117","article-title":"Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis","volume":"6","author":"Conery","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib51","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.22860","article-title":"Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma","volume":"49","author":"Nagata","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","article-title":"A Mutant-p53\/Smad complex opposes p63 to empower TGFbeta-induced metastasis","volume":"137","author":"Adorno","year":"2009","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib53","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI36125","article-title":"Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter","volume":"120","author":"Hannigan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.01.030_bib54","article-title":"The dual role of TGFbeta in human cancer: from tumor suppression to cancer metastasis","volume":"2012","author":"Lebrun","year":"2012","journal-title":"ISRN Mol Biol"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3zeta turns TGF-beta's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"Xu","year":"2015","journal-title":"Canc. Cell"},{"issue":"W1","key":"10.1016\/j.canlet.2021.01.030_bib56","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib57","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.canlet.2021.01.030_bib58","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1073\/pnas.0908869107","article-title":"MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function","volume":"107","author":"Yu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.canlet.2021.01.030_bib59","doi-asserted-by":"crossref","first-page":"E3820","DOI":"10.1073\/pnas.1308419110","article-title":"Actin-related protein2\/3 complex regulates tight junctions and terminal differentiation to promote epidermal barrier formation","volume":"110","author":"Zhou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(00)81559-7","article-title":"Directed actin polymerization is the driving force for epithelial cell-cell adhesion","volume":"100","author":"Vasioukhin","year":"2000","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib61","first-page":"2215","article-title":"Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation","volume":"50","author":"Rao","year":"1990","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/molehr\/3.4.275","article-title":"Adhesiveness of the free surface of a human endometrial monolayer for trophoblast as related to actin cytoskeleton","volume":"3","author":"Thie","year":"1997","journal-title":"Mol. Hum. Reprod."},{"issue":"9","key":"10.1016\/j.canlet.2021.01.030_bib63","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1096\/fj.12-204008","article-title":"Annexin A2 is critical for embryo adhesiveness to the human endometrium by RhoA activation through F-actin regulation","volume":"26","author":"Garrido-Gomez","year":"2012","journal-title":"Faseb. J."},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib64","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0002-9378(72)90861-7","article-title":"Establishment of a cell line of human endometrial adenocarcinoma in vitro","volume":"114","author":"Kuramoto","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-018-2807-7","article-title":"The expression of the MSC-marker CD73 and of NF2\/Merlin are correlated in meningiomas","volume":"138","author":"Kirches","year":"2018","journal-title":"J. Neuro Oncol."},{"issue":"Pt 2","key":"10.1016\/j.canlet.2021.01.030_bib66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3560377","article-title":"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association","volume":"356","author":"James","year":"2001","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.canlet.2021.01.030_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2010.10.008","article-title":"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex","volume":"19","author":"Gladden","year":"2010","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2007.09.002","article-title":"Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth","volume":"29","author":"James","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/labinvest.3700236","article-title":"Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1","volume":"85","author":"Zen","year":"2005","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib70","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/0008-5472.CAN-03-1772","article-title":"Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging","volume":"64","author":"Deane","year":"2004","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.canlet.2021.01.030_bib71","first-page":"2447","article-title":"TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1\/WAF1 and p27Kip1","volume":"13","author":"Florenes","year":"1996","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039381","article-title":"Effects of activin and TGFbeta on p21 in colon cancer","volume":"7","author":"Bauer","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.canlet.2021.01.030_bib73","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","article-title":"Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism","volume":"92","author":"Datto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.canlet.2021.01.030_bib74","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cas.13196","article-title":"Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer","volume":"108","author":"Yamawaki","year":"2017","journal-title":"Canc. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2021.01.030_bib75","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<318::AID-PATH925>3.0.CO;2-0","article-title":"Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma","volume":"183","author":"Ito","year":"1997","journal-title":"J. Pathol."},{"issue":"14","key":"10.1016\/j.canlet.2021.01.030_bib76","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.febslet.2012.02.037","article-title":"Regulation of EMT by TGFbeta in cancer","volume":"586","author":"Heldin","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2021.01.030_bib77","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2020.00508","article-title":"CD73's potential as an immunotherapy target in gastrointestinal cancers","volume":"11","author":"Harvey","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.01.030_bib78","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1749-6632.1991.tb37884.x","article-title":"Establishment and characterization of human endometrial cancer cell lines","volume":"622","author":"Kuramoto","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2021.01.030_bib79","series-title":"CCLE Cancer Cell Line Encyclopedia","author":"Harvard","year":"2020"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<247::AID-IJC17>3.0.CO;2-0","article-title":"TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor","volume":"83","author":"Kornmann","year":"1999","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2021.01.030_bib81","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1038\/ncomms11581","article-title":"Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin","volume":"7","author":"Fuste","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135748","article-title":"PEAK1 acts as a molecular switch to regulate context-dependent TGFbeta responses in breast cancer","volume":"10","author":"Agajanian","year":"2015","journal-title":"PloS One"},{"issue":"24","key":"10.1016\/j.canlet.2021.01.030_bib83","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1158\/0008-5472.CAN-10-1354","article-title":"Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth","volume":"70","author":"Micalizzi","year":"2010","journal-title":"Canc. Res."},{"issue":"5","key":"10.1016\/j.canlet.2021.01.030_bib84","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","article-title":"TGF-beta tumor suppression through a lethal EMT","volume":"164","author":"David","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2021.01.030_bib85","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bjc.2012.95","article-title":"NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity","volume":"106","author":"Wang","year":"2012","journal-title":"Br. J. Canc."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib86","doi-asserted-by":"crossref","first-page":"C1079","DOI":"10.1152\/ajpcell.00285.2019","article-title":"Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73)","volume":"317","author":"Minor","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/carcin\/bgy154","article-title":"Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer","volume":"40","author":"Koivisto","year":"2019","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1078-0432.CCR-15-1181","article-title":"CD73 expression is an independent prognostic factor in prostate cancer","volume":"22","author":"Leclerc","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/path.4930","article-title":"Conditional abrogation of transforming growth factor-beta receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice","volume":"243","author":"Gao","year":"2017","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1095\/biolreprod.114.125146","article-title":"Constitutive activation of transforming growth factor Beta receptor 1 in the mouse uterus impairs uterine morphology and function","volume":"92","author":"Gao","year":"2015","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.canlet.2021.01.030_bib91","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1091\/mbc.e04-02-0097","article-title":"Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells","volume":"15","author":"Murphy","year":"2004","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.canlet.2021.01.030_bib92","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.devcel.2015.01.011","article-title":"Cell density sensing alters TGF-beta signaling in a cell-type-specific manner, independent from Hippo pathway activation","volume":"32","author":"Nallet-Staub","year":"2015","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib93","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcp.22135","article-title":"Vectorial TGFbeta signaling in polarized intestinal epithelial cells","volume":"224","author":"Yakovich","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2021.01.030_bib94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-10-67","article-title":"Differential roles of Smad2 and Smad3 in the regulation of TGF-beta1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1","volume":"10","author":"Ungefroren","year":"2011","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2021.01.030_bib95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-beta mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2021.01.030_bib96","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/MCB.01404-07","article-title":"Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice","volume":"28","author":"Pangas","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.canlet.2021.01.030_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199688","article-title":"Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas","volume":"13","author":"Xu","year":"2018","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.canlet.2021.01.030_bib98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijc.20130","article-title":"Molecular alterations associated with cyclin D1 overexpression in endometrial cancer","volume":"110","author":"Moreno-Bueno","year":"2004","journal-title":"Int. J. Canc."},{"issue":"38","key":"10.1016\/j.canlet.2021.01.030_bib99","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/sj.onc.1206868","article-title":"Cyclin D1 gene (CCND1) mutations in endometrial cancer","volume":"22","author":"Moreno-Bueno","year":"2003","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:54:43Z","timestamp":1759593283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":99,"alternative-id":["S0304383521000628"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.01.030","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of CD73 shifts transforming growth factor-\u03b21 (TGF-\u03b21) from tumor suppressor to promoter in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}